pipette
ESEspañol

In situ CAR-M engineered by liposomal mRNA nanomedicine remodels fibrotic microenvironment for ameliorating liver fibrosis

Hong Ping Xiao, 黎小霞, Kaimin Cai, Yifei Leng, Xiaoyan Miao, Tinghui Yin, Xintao Shuai, Jie Ren

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Collectively, our customized LNP-mediated in situ engineering of liver macrophages into CAR-Ms enables precise antifibrotic intervention for liver fibrosis and circumvents the cumbersome ex vivo CAR-M preparation process.

Appeared: Sunday, October 25. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.aeh6590